Innophos Holdings (NASDAQ: IPHS) is one of 34 public companies in the “Commodity Chemicals” industry, but how does it contrast to its rivals? We will compare Innophos Holdings to related businesses based on the strength of its analyst recommendations, profitability, valuation, earnings, dividends, risk and institutional ownership.

Analyst Recommendations

This is a summary of recent ratings and target prices for Innophos Holdings and its rivals, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Innophos Holdings 0 0 1 0 3.00
Innophos Holdings Competitors 104 772 1154 34 2.54

Innophos Holdings currently has a consensus target price of $56.00, suggesting a potential upside of 13.29%. As a group, “Commodity Chemicals” companies have a potential downside of 1.45%. Given Innophos Holdings’ stronger consensus rating and higher probable upside, equities analysts clearly believe Innophos Holdings is more favorable than its rivals.

Valuation and Earnings

This table compares Innophos Holdings and its rivals top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
Innophos Holdings $698.91 million $116.47 million 21.68
Innophos Holdings Competitors $4.16 billion $893.20 million 33.82

Innophos Holdings’ rivals have higher revenue and earnings than Innophos Holdings. Innophos Holdings is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.


This table compares Innophos Holdings and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Innophos Holdings 6.46% 13.79% 7.51%
Innophos Holdings Competitors -23.86% 24.81% 5.91%

Risk and Volatility

Innophos Holdings has a beta of 0.89, indicating that its stock price is 11% less volatile than the S&P 500. Comparatively, Innophos Holdings’ rivals have a beta of 1.17, indicating that their average stock price is 17% more volatile than the S&P 500.


Innophos Holdings pays an annual dividend of $1.92 per share and has a dividend yield of 3.9%. Innophos Holdings pays out 84.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. As a group, “Commodity Chemicals” companies pay a dividend yield of 1.8% and pay out 63.1% of their earnings in the form of a dividend.

Institutional & Insider Ownership

94.3% of Innophos Holdings shares are held by institutional investors. Comparatively, 69.0% of shares of all “Commodity Chemicals” companies are held by institutional investors. 2.3% of Innophos Holdings shares are held by insiders. Comparatively, 8.2% of shares of all “Commodity Chemicals” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.


Innophos Holdings rivals beat Innophos Holdings on 8 of the 15 factors compared.

Innophos Holdings Company Profile

Innophos Holdings, Inc. is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other. The Company has four principal product lines: Specialty Ingredients; Food and Technical Grade Purified Phosphoric Acid (PPA); Technical Grade Sodium Tripolyphosphate (STPP), & Detergent Grade PPA, and GTSP & Other. The Company’s bioactive mineral ingredients are mineral-based ingredients for food, beverage and dietary supplement end markets that are manufactured to be readily digestible. The Company has its manufacturing facilities located throughout the United States, Canada, Mexico and China.

Receive News & Ratings for Innophos Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos Holdings Inc. and related companies with's FREE daily email newsletter.